http://orcid.org/0000-0001-9111-1539
References
- Cora-Locatelli G, Greenberg BD, Martin JD, et al. Valproate monotherapy in an SRI-intolerant OCD patient. J Clin Psychiatry. 1998;59:82. doi: 10.4088/JCP.v59n0207b
- Wermurth BM, Davis KL, Hollister LE, et al. Phenytoin treatment of the binge-eating syndrome. Am J Psychiatry. 1977;134:1249–1253. doi: 10.1176/ajp.134.11.1249
- McGrath MJ, Campbell KM, Parks CR, et al. Glutamatergic drugs exacerbate behaviour in a transgenic model of comorbid Tourette’s syndrome and obsessive-compulsive disorder. Brain Res. 2000;877:23–30. doi: 10.1016/S0006-8993(00)02646-9
- Chapman AG. Glutamate receptors in epilepsy. Prog Brain Res. 1998;116:371–383. doi: 10.1016/S0079-6123(08)60449-5
- Meldrum BS. The role of glutamate in epilepsy and other CNS disorders. Neurology. 1994;44:14–23.
- Lynch BA, Lambeng N, Nocka K, et al. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci USA. 2004;101:9861–9866. doi: 10.1073/pnas.0308208101
- Ettinger AB. Psychotropic effects of antiepileptic drugs. Neurology. 2006;67:1916–1925. doi: 10.1212/01.wnl.0000247045.85646.c0
- Hurtado B, Koepp MJ, Sander JW, et al. The impact of levetiracetam on challenging behavior. Epilepsy Behav. 2006;8:588–592. doi: 10.1016/j.yebeh.2006.01.003
- Rugino TA, Samsock TC. Levetiracetam in autistic children: an open-label study. J Dev Behav Pediatr. 2002;23:225–230. doi: 10.1097/00004703-200208000-00006
- Helmstaedter C, Fritz NE, Kockelmann E, et al. Positive and negative psychotropic effects of levetiracetam. Epilepsy Behav. 2008;13:535–541. doi: 10.1016/j.yebeh.2008.05.012
- Sherer M, Padilla S. A case of obsessiveness induced by levetiracetam in a patient with epilepsy, intellectual disability and pervasive developmental disorder. Ment Health Asp Dev Disabil. 2008;11(1):1–4.
- Gates JR, Folland C, Berhow J, et al. Behavioral side effects of levetiracetam. Am Epilepsy Soc. 2002:1–4.
- Lee JJ, Song HS, Hwang YH, et al. Psychiatric symptoms and quality of life in patients with drug-refractory epilepsy receiving adjunctive levetiracetam therapy. J Clin Neurol. 2011;7:128–136. doi: 10.3988/jcn.2011.7.3.128
- Fujikawa M, Kishimoto Y, Kakisaka Y, et al. Obsessive-compulsive behavior induced by levetiracetam. J Child Neurol. 2014:1–3.
- Khouzam HR. Levetiracetam treatment of refractory obsessive-compulsive disorder. Ann Psychiatry Ment Health. 2015;3(6):1045.